Call For Papers
The ICOIPM aims to explore emerging trends and future directions in research and innovation. It provides a collaborative platform for researchers and professionals to share ideas that shape the future of their respective domains.
The conference highlights advancements in Oncology, encouraging innovative, solution-oriented research that addresses global challenges and technological evolution.
Authors are invited to submit papers addressing, but not limited to, the following areas:
- Immunotherapy breakthroughs in oncology
- Precision medicine in cancer treatment
- Innovative approaches to cancer immunology
- Clinical trials in immunotherapy
- Role of biomarkers in immunotherapy
- Patient responses to immunotherapy treatments
- Ethical considerations in immunotherapy research
- Global impact of immunotherapy advancements
- Combination therapies in cancer treatment
- Long-term outcomes of immunotherapy
- Access to immunotherapy in diverse populations
- Emerging technologies in immunotherapy
- Patient education on immunotherapy options
- Clinical guidelines for immunotherapy use
- Impact of immunotherapy on quality of life
- Cost-effectiveness of immunotherapy treatments
- Collaboration in immunotherapy research
- Innovations in cancer vaccine development
- Role of the microbiome in immunotherapy
- Future directions in cancer immunotherapy
Assessment
Submissions will be assessed for originality, innovation, and relevance. Accepted papers will be presented at the conference and considered for publication opportunities in reputed academic platforms.
Registration
Participants are requested to complete the registration process following acceptance of their paper. Registration ensures inclusion in the conference schedule and official records.
Publication
All accepted manuscripts will be eligible for publication consideration in conference proceedings and associated academic journals.